Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1393433

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1393433

MEA Chinese Hamster Ovary (CHO) cells Market - Industry Trends and Forecast to 2033

PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Middle East and Africa Chinese Hamster Ovary (CHO) Cells market is projected to register a CAGR of 6.0% in the forecast period of 2023 to 2030. The new market report contains data for historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation

Middle East and Africa Chinese Hamster Ovary (CHO) Cells Market, By Type (Services and Product), System (Metabolic Selection System, Antibiotic Selection System and Others), application(Biologics and Medical Research), End-user (Biopharmaceutical Companies, Biotechnology Companies, Clinical Development and Manufacturing Organizations, Clinical Research Organizations, Academic Institutes and Research Organizations, and Others), Distribution Channel (Direct Tenders, Retail Sales and Others),Country (Brazil, Argentina, Saudi Arabia, U.A.E., Egypt, Qatar, Kuwait, Oman, Bahrain and Rest of the Middle East and Africa) - Industry Trends and Forecast to 2030.

Overview of Middle East and Africa Chinese Hamster Ovary (CHO) Cells Market Dynamics

  • Drivers
  • Rising use of CHO cells in the genetic study
  • Growing demand for biopharmaceuticals
  • Restraint
  • Rising number of applications of CHO cells
  • Opportunity
  • Rising number of applications of CHO cells

Market Players

Some major companies operating in the Middle East and Africa Chinese Hamster Ovary (CHO) Cells market are:

  • Thermo Fisher Scientific Inc. (U.S.)
  • AcceGen (U.S.)
  • RayBiotech Life, Inc. (U.S.)
  • CLS Cell Lines Service GmbH (Germany)
  • BPS Bioscience, Inc. (U.S.)
  • GenTarget Inc. (U.S.)
  • Merck KGaA (Germany)
  • Promega Corporation (U.S.)
  • Abeomics (U.S.)
  • Applied Biological Materials Inc. (abm) (Canada)
  • ATCC (U.S.)
  • Sartorius AG (Germany)
  • Lonza (Switzerland)
  • Horizon Discovery Ltd. (U.K.)

TABLE OF CONTENTS

1 INTRODUCTION 18

  • 1.1 OBJECTIVES OF THE STUDY 18
  • 1.2 MARKET DEFINITION 18
  • 1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET 18
  • 1.4 LIMITATIONS 20
  • 1.5 MARKETS COVERED 20

2 MARKET SEGMENTATION 23

  • 2.1 MARKETS COVERED 23
  • 2.2 GEOGRAPHICAL SCOPE 24
  • 2.3 YEARS CONSIDERED FOR THE STUDY 25
  • 2.4 CURRENCY AND PRICING 25
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 26
  • 2.6 MULTIVARIATE MODELLING 29
  • 2.7 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELL, BY TYPE, LIFELINE CURVE 29
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 30
  • 2.9 DBMR MARKET POSITION GRID 31
  • 2.10 MARKET APPLICATION COVERAGE GRID 32
  • 2.11 VENDOR SHARE ANALYSIS 33
  • 2.12 SECONDARY SOURCES 34
  • 2.13 ASSUMPTIONS 34

3 EXECUTIVE SUMMARY 35

4 PREMIUM INSIGHTS 38

  • 4.1 PESTEL ANALYSIS 39
  • 4.2 PORTER'S FIVE FORCES 40

5 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET, REGULATIONS 41

6 MARKET OVERVIEW 43

  • 6.1 DRIVERS 45
    • 6.1.1 RISING USE OF CHO CELLS IN THE GENETIC STUDY 45
    • 6.1.2 GROWING DEMAND FOR BIOPHARMACEUTICALS 46
    • 6.1.3 RISING INVESTMENTS IN BIOTECHNOLOGY R&D 46
    • 6.1.4 RISING DEMAND FOR MONOCLONAL ANTIBODIES 48

  • 6.2 RESTRAINTS 49
    • 6.2.1 HIGH-COST OF CHO CELL-BASED PRODUCTION 49
    • 6.2.2 STRICT REGULATORY REQUIREMENTS FOR CHO CELL-BASED PRODUCTION 49
  • 6.3 OPPORTUNITIES 50
    • 6.3.1 CONTINUOUS DEVELOPMENT OF CELL CULTURE TECHNOLOGIES 50
    • 6.3.2 RISING NUMBER OF APPLICATIONS OF CHO CELLS 52
  • 6.4 CHALLENGES 53
    • 6.4.1 TIME-CONSUMING AND INCONSISTENCY IN CHO CELL LINE DEVELOPMENT PROCESS 53
    • 6.4.2 CONTAMINATION RISK OF CHO CELL CULTURES 54

7 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE 55

  • 7.1 OVERVIEW 56
  • 7.2 SERVICES 57
  • 7.3 PRODUCT 58
    • 7.3.1 CHO-DXB11 58
    • 7.3.2 CHO-K1 59
      • 7.3.2.1 CHO-K1 ATCC 59
      • 7.3.2.2 CHO-K1 ECACC 59
      • 7.3.2.3 Others 59
    • 7.3.3 CHO-DG44 59
    • 7.3.4 CHO-S 59
    • 7.3.5 OTHERS 59

8 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM 60

  • 8.1 OVERVIEW 61
  • 8.2 METABOLIC SELECTION SYSTEM 62
  • 8.3 ANTIBIOTIC SELECTION SYSTEM 63
  • 8.4 OTHERS 63

9 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION 64

  • 9.1 OVERVIEW 65
  • 9.2 BIOLOGICS 66
    • 9.2.1 MONOCLONAL ANTIBODIES 67
    • 9.2.2 ENZYMES 67
    • 9.2.3 CYTOKINES 67
    • 9.2.4 CLOTTING FACTORS 67
    • 9.2.5 HORMONES 67
    • 9.2.6 FC-FUSION PROTIEN 67
    • 9.2.7 OTHERS 68
  • 9.3 MEDICAL RESEARCH 68

10 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER 69

  • 10.1 OVERVIEW 70
  • 10.2 BIOPHARMACEUTICAL COMPANIES 71
    • 10.2.1 MEDIUM 72
    • 10.2.2 SMALL 72
  • 10.3 BIOTECHNOLOGY COMPANIES 72
    • 10.3.1 MEDIUM 73
    • 10.3.2 SMALL 73
  • 10.4 CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS 73
    • 10.4.1 MEDIUM 74
    • 10.4.2 SMALL 74
  • 10.5 CLINICAL RESEARCH ORGANIZATIONS 74
    • 10.5.1 MEDIUM 75
    • 10.5.2 SMALL 75
  • 10.6 ACADEMIC INSTITUTES AND RESEARCH ORGANIZATIONS 75
  • 10.7 OTHERS 76

11 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL 77

  • 11.1 OVERVIEW 78
  • 11.2 DIRECT TENDERS 79
  • 11.3 RETAIL SALES 80
  • 11.4 OTHERS 80

12 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION 81

  • 12.1 MIDDLE EAST AND AFRICA 83

13 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, COMPANY LANDSCAPE 122

  • 13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 122

14 SWOT ANALYSIS 123

15 COMPANY PROFILE 124

  • 15.1 LONZA 124
    • 15.1.1 COMPANY SNAPSHOT 124
    • 15.1.2 REVENUE ANALYSIS 124
    • 15.1.3 COMPANY SHARE ANALYSIS 125
    • 15.1.4 PRODUCT PORTFOLIO 125
    • 15.1.5 RECENT DEVELOPMENT 125
  • 15.2 SARTORIUS AG 126
    • 15.2.1 COMPANY SNAPSHOT 126
    • 15.2.2 REVENUE ANALYSIS 126
    • 15.2.3 COMPANY SHARE ANALYSIS 127
    • 15.2.4 PRODUCT PORTFOLIO 127
    • 15.2.5 RECENT DEVELOPMENT 127
  • 15.3 MERCK KGAA 128
    • 15.3.1 COMPANY SNAPSHOT 128
    • 15.3.2 REVENUE ANALYSIS 128
    • 15.3.3 COMPANY SHARE ANALYSIS 129
    • 15.3.4 PRODUCT PORTFOLIO 129
    • 15.3.5 RECENT DEVELOPMENT 129
  • 15.4 CYTIVA 130
    • 15.4.1 COMPANY SNAPSHOT 130
    • 15.4.2 COMPANY SHARE ANALYSIS 130
    • 15.4.3 PRODUCT PORTFOLIO 130
    • 15.4.4 RECENT DEVELOPMENT 130
  • 15.5 THERMO FISHER SCIENTIFIC INC. 131
    • 15.5.1 COMPANY SNAPSHOT 131
    • 15.5.2 REVENUE ANALYSIS 131
    • 15.5.3 COMPANY SHARE ANALYSIS 132
    • 15.5.4 PRODUCT PORTFOLIO 132
    • 15.5.5 RECENT DEVELOPMENT 132
  • 15.6 ABEOMICS 133
    • 15.6.1 COMPANY SNAPSHOT 133
    • 15.6.2 PRODUCT PORTFOLIO 133
    • 15.6.3 RECENT DEVELOPMENT 133
  • 15.7 ACCEGEN 134
    • 15.7.1 COMPANY SNAPSHOT 134
    • 15.7.2 PRODUCT PORTFOLIO 134
    • 15.7.3 RECENT DEVELOPMENT 134

  • 15.8 APPLIED BIOLOGICAL MATERIALS INC. (ABM) 135
    • 15.8.1 COMPANY SNAPSHOT 135
    • 15.8.2 PRODUCT PORTFOLIO 135
    • 15.8.3 RECENT DEVELOPMENT 135
  • 15.9 ATCC 136
    • 15.9.1 COMPANY SNAPSHOT 136
    • 15.9.2 PRODUCT PORTFOLIO 136
    • 15.9.3 RECENT DEVELOPMENT 136
  • 15.10 BPS BIOSCIENCE, INC. 137
    • 15.10.1 COMPANY SNAPSHOT 137
    • 15.10.2 PRODUCT PORTFOLIO 137
    • 15.10.3 RECENT DEVELOPMENT 137
  • 15.11 CLS CELL LINES SERVICE GMBH 138
    • 15.11.1 COMPANY SNAPSHOT 138
    • 15.11.2 PRODUCT PORTFOLIO 138
    • 15.11.3 RECENT DEVELOPMENT 138
  • 15.12 CURIA MIDDLE EAST AND AFRICA, INC. 139
    • 15.12.1 COMPANY SNAPSHOT 139
    • 15.12.2 PRODUCT PORTFOLIO 139
    • 15.12.3 RECENT DEVELOPMENT 139
  • 15.13 GENTARGET INC. 140
    • 15.13.1 COMPANY SNAPSHOT 140
    • 15.13.2 PRODUCT PORTFOLIO 140
    • 15.13.3 RECENT DEVELOPMENT 140
  • 15.14 GTP BIOWAYS 141
    • 15.14.1 COMPANY SNAPSHOT 141
    • 15.14.2 PRODUCT PORTFOLIO 141
    • 15.14.3 RECENT DEVELOPMENT 141
  • 15.15 HORIZON DISCOVERY LTD. 142
    • 15.15.1 COMPANY SNAPSHOT 142
    • 15.15.2 PRODUCT PORTFOLIO 142
    • 15.15.3 RECENT DEVELOPMENT 142
  • 15.16 PROMEGA CORPORATION 143
    • 15.16.1 COMPANY SNAPSHOT 143
    • 15.16.2 PRODUCT PORTFOLIO 143
    • 15.16.3 RECENT DEVELOPMENT 143
  • 15.17 RAYBIOTECH LIFE, INC. 144
    • 15.17.1 COMPANY SNAPSHOT 144
    • 15.17.2 PRODUCT PORTFOLIO 144
    • 15.17.3 RECENT DEVELOPMENT 144

16 QUESTIONNAIRE 145

17 RELATED REPORTS 149

LIST OF TABLES

  • TABLE 1 ICH GUIDELINES FOR CHO CELL-BASED PRODUCTS 42
  • TABLE 2 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2022-2030 (USD THOUSAND) 57
  • TABLE 3 MIDDLE EAST AND AFRICA SERVICES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 57
  • TABLE 4 MIDDLE EAST AND AFRICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 58
  • TABLE 5 MIDDLE EAST AND AFRICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 58
  • TABLE 6 MIDDLE EAST AND AFRICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 59
  • TABLE 7 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 62
  • TABLE 8 MIDDLE EAST AND AFRICA METABOLIC SELECTION SYSTEM IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
  • TABLE 9 MIDDLE EAST AND AFRICA ANTIBIOTIC SELECTION SYSTEM IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 63
  • TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 63
  • TABLE 11 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 66
  • TABLE 12 MIDDLE EAST AND AFRICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 66
  • TABLE 13 MIDDLE EAST AND AFRICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 67
  • TABLE 14 MIDDLE EAST AND AFRICA MEDICAL RESEARCH IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
  • TABLE 15 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 71
  • TABLE 16 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
  • TABLE 17 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 72
  • TABLE 18 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 72
  • TABLE 19 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 73
  • TABLE 20 MIDDLE EAST AND AFRICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
  • TABLE 21 MIDDLE EAST AND AFRICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 74
  • TABLE 22 MIDDLE EAST AND AFRICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 74
  • TABLE 23 MIDDLE EAST AND AFRICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 75
  • TABLE 24 MIDDLE EAST AND AFRICA ACADEMIC INSTITUTES AND RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
  • TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
  • TABLE 26 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD THOUSAND) 79
  • TABLE 27 MIDDLE EAST AND AFRICA DIRECT TENDERS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
  • TABLE 28 MIDDLE EAST AND AFRICA RETAIL SALES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
  • TABLE 29 MIDDLE EAST AND AFRICA OTHERS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
  • TABLE 30 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 83
  • TABLE 31 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 83
  • TABLE 32 MIDDLE EAST AND AFRICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 83
  • TABLE 33 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 84
  • TABLE 34 MIDDLE EAST AND AFRICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 84
  • TABLE 35 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 84
  • TABLE 36 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 84
  • TABLE 37 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 85
  • TABLE 38 MIDDLE EAST AND AFRICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 85
  • TABLE 39 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 85
  • TABLE 40 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 86
  • TABLE 41 MIDDLE EAST AND AFRICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 86
  • TABLE 42 MIDDLE EAST AND AFRICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 86
  • TABLE 43 MIDDLE EAST AND AFRICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 86
  • TABLE 44 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 87
  • TABLE 45 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 88
  • TABLE 46 SAUDI ARABIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 88
  • TABLE 47 SAUDI ARABIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 88
  • TABLE 48 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 88
  • TABLE 49 SAUDI ARABIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 89
  • TABLE 50 SAUDI ARABIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 89
  • TABLE 51 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 89
  • TABLE 52 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 89
  • TABLE 53 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 90
  • TABLE 54 SAUDI ARABIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 90
  • TABLE 55 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 90
  • TABLE 56 SAUDI ARABIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
  • TABLE 57 SAUDI ARABIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
  • TABLE 58 SAUDI ARABIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
  • TABLE 59 SAUDI ARABIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
  • TABLE 60 SAUDI ARABIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 92
  • TABLE 61 U.A.E. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 93
  • TABLE 62 U.A.E. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 93
  • TABLE 63 U.A.E. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 93
  • TABLE 64 U.A.E. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 93
  • TABLE 65 U.A.E. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 94
  • TABLE 66 U.A.E. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 94
  • TABLE 67 U.A.E. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 94
  • TABLE 68 U.A.E. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 94
  • TABLE 69 U.A.E. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 94
  • TABLE 70 U.A.E. BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 95
  • TABLE 71 U.A.E. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 95
  • TABLE 72 U.A.E. BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 95
  • TABLE 73 U.A.E. BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 96
  • TABLE 74 U.A.E. CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 96
  • TABLE 75 U.A.E. CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 96
  • TABLE 76 U.A.E. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 96
  • TABLE 77 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 97
  • TABLE 78 SOUTH AFRICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 97
  • TABLE 79 SOUTH AFRICA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 97
  • TABLE 80 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 97
  • TABLE 81 SOUTH AFRICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 98
  • TABLE 82 SOUTH AFRICA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 98
  • TABLE 83 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 98
  • TABLE 84 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 98
  • TABLE 85 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 99
  • TABLE 86 SOUTH AFRICA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 99
  • TABLE 87 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 99
  • TABLE 88 SOUTH AFRICA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 100
  • TABLE 89 SOUTH AFRICA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 100
  • TABLE 90 SOUTH AFRICA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 100
  • TABLE 91 SOUTH AFRICA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 100
  • TABLE 92 SOUTH AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 100
  • TABLE 93 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 101
  • TABLE 94 EGYPT PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 101
  • TABLE 95 EGYPT PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 101
  • TABLE 96 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 101
  • TABLE 97 EGYPT CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 102
  • TABLE 98 EGYPT CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 102
  • TABLE 99 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 102
  • TABLE 100 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 102
  • TABLE 101 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 102
  • TABLE 102 EGYPT BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 103
  • TABLE 103 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 103
  • TABLE 104 EGYPT BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
  • TABLE 105 EGYPT BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 106 EGYPT CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 107 EGYPT CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 108 EGYPT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 104
  • TABLE 109 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 105
  • TABLE 110 QATAR PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 105
  • TABLE 111 QATAR PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 105
  • TABLE 112 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 105
  • TABLE 113 QATAR CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 106
  • TABLE 114 QATAR CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 106
  • TABLE 115 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 106
  • TABLE 116 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 106
  • TABLE 117 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 106
  • TABLE 118 QATAR BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 107
  • TABLE 119 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 107
  • TABLE 120 QATAR BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 107
  • TABLE 121 QATAR BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 108
  • TABLE 122 QATAR CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 108
  • TABLE 123 QATAR CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 108
  • TABLE 124 QATAR CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 108
  • TABLE 125 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 109
  • TABLE 126 KUWAIT PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 109
  • TABLE 127 KUWAIT PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 109
  • TABLE 128 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 109
  • TABLE 129 KUWAIT CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 110
  • TABLE 130 KUWAIT CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 110
  • TABLE 131 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 110
  • TABLE 132 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 110
  • TABLE 133 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 111
  • TABLE 134 KUWAIT BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 111
  • TABLE 135 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 111
  • TABLE 136 KUWAIT BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 112
  • TABLE 137 KUWAIT BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 112
  • TABLE 138 KUWAIT CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 112
  • TABLE 139 KUWAIT CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 112
  • TABLE 140 KUWAIT CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 113
  • TABLE 141 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 113
  • TABLE 142 OMAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 113
  • TABLE 143 OMAN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 114
  • TABLE 144 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 114
  • TABLE 145 OMAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 114
  • TABLE 146 OMAN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 114
  • TABLE 147 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 114
  • TABLE 148 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 115
  • TABLE 149 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 115
  • TABLE 150 OMAN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 115
  • TABLE 151 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 116
  • TABLE 152 OMAN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 116
  • TABLE 153 OMAN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 116
  • TABLE 154 OMAN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 116
  • TABLE 155 OMAN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 117
  • TABLE 156 OMAN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 117
  • TABLE 157 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 117
  • TABLE 158 BAHRAIN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 118
  • TABLE 159 BAHRAIN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 118
  • TABLE 160 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 118
  • TABLE 161 BAHRAIN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 118
  • TABLE 162 BAHRAIN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 119
  • TABLE 163 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 119
  • TABLE 164 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 119
  • TABLE 165 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 119
  • TABLE 166 BAHRAIN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 120
  • TABLE 167 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 120
  • TABLE 168 BAHRAIN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 120
  • TABLE 169 BAHRAIN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 121
  • TABLE 170 BAHRAIN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 121
  • TABLE 171 BAHRAIN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 121
  • TABLE 172 BAHRAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 121
  • TABLE 173 REST OF MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 121

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: SEGMENTATION 23
  • FIGURE 2 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: DATA TRIANGULATION 26
  • FIGURE 3 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: DROC ANALYSIS 27
  • FIGURE 4 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS 28
  • FIGURE 5 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: COMPANY RESEARCH ANALYSIS 28
  • FIGURE 6 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: INTERVIEW DEMOGRAPHICS 30
  • FIGURE 7 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: DBMR MARKET POSITION GRID 31
  • FIGURE 8 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: MARKET APPLICATION COVERAGE GRID 32
  • FIGURE 9 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: VENDOR SHARE ANALYSIS 33
  • FIGURE 10 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET: SEGMENTATION 37
  • FIGURE 11 GROWING DEMAND FOR BIOPHARMACEUTICALS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030 38
  • FIGURE 12 SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET IN THE FORECAST PERIOD OF 2023 & 2030 38
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY CELLS (CHO) MARKET 44
  • FIGURE 14 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2022 56
  • FIGURE 15 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2022 61
  • FIGURE 16 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2022 65
  • FIGURE 17 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2022 70
  • FIGURE 18 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2022 78
  • FIGURE 19 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SNAPSHOT (2022) 82
  • FIGURE 20 MIDDLE EAST AND AFRICA CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2022 (%) 122
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!